These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30121076)

  • 1. Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome.
    Takahashi H; Iwahashi N; Kirigaya J; Kataoka S; Minamimoto Y; Gohbara M; Abe T; Okada K; Matsuzawa Y; Konishi M; Maejima N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Cardiovasc Diabetol; 2018 Aug; 17(1):116. PubMed ID: 30121076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of day-to-day glucose variability in patients after acute coronary syndrome.
    Miyoshi M; Uzui H; Shimizu T; Aiki T; Shiomi Y; Nodera M; Ikeda H; Tama N; Hasegawa K; Morishita T; Ishida K; Miyazaki S; Tada H
    BMC Cardiovasc Disord; 2021 Oct; 21(1):490. PubMed ID: 34629051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic Variability on Continuous Glucose Monitoring System Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome.
    Kataoka S; Gohbara M; Iwahashi N; Sakamaki K; Nakachi T; Akiyama E; Maejima N; Tsukahara K; Hibi K; Kosuge M; Ebina T; Umemura S; Kimura K
    Circ J; 2015; 79(10):2246-54. PubMed ID: 26227393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis evaluation of universal acute coronary syndrome: the interplay between SYNTAX score and ApoB/ApoA1.
    Wang X; Wang Z; Li B; Yang P
    BMC Cardiovasc Disord; 2020 Jun; 20(1):293. PubMed ID: 32539722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors.
    Zhang X; Du Y; Zhang T; Zhao Z; Guo Q; Ma X; Shi D; Zhou Y
    Cardiovasc Diabetol; 2024 Jul; 23(1):270. PubMed ID: 39044255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia.
    Kuhl J; Jörneskog G; Wemminger M; Bengtsson M; Lundman P; Kalani M
    Cardiovasc Diabetol; 2015 Sep; 14():120. PubMed ID: 26382578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum malondialdehyde-modified low-density lipoprotein levels on admission predict prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Amioka N; Miyoshi T; Otsuka H; Yamada D; Takaishi A; Ueeda M; Hirohata S; Ito H
    J Cardiol; 2019 Sep; 74(3):258-266. PubMed ID: 30898480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between glycemic variability and major adverse cardiovascular and cerebrovascular events (MACCE) in patients with acute coronary syndrome during 30-day follow-up.
    Xia J; Xu J; Li B; Liu Z; Hao H; Yin C; Xu D
    Clin Chim Acta; 2017 Mar; 466():162-166. PubMed ID: 28111271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.
    Akasaka T; Sueta D; Tabata N; Takashio S; Yamamoto E; Izumiya Y; Tsujita K; Kojima S; Kaikita K; Matsui K; Hokimoto S
    J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of glycemic variability on left ventricular reverse remodeling after the first episode of ST-segment elevation myocardial infarction.
    Hanajima Y; Iwahashi N; Kirigaya J; Horii M; Minamimoto Y; Gohbara M; Abe T; Okada K; Matsuzawa Y; Kosuge M; Ebina T; Hibi K
    Cardiovasc Diabetol; 2023 Aug; 22(1):202. PubMed ID: 37542320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Variability Determined by Continuous Glucose Monitoring System Predicts Left Ventricular Remodeling in Patients With a First ST-Segment Elevation Myocardial Infarction.
    Gohbara M; Iwahashi N; Kataoka S; Hayakawa Y; Sakamaki K; Akiyama E; Maejima N; Tsukahara K; Hibi K; Kosuge M; Ebina T; Umemura S; Kimura K
    Circ J; 2015; 79(5):1092-9. PubMed ID: 25739857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome - Optical Coherence Tomography Study.
    Gohbara M; Hibi K; Mitsuhashi T; Maejima N; Iwahashi N; Kataoka S; Akiyama E; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    Circ J; 2016; 80(1):202-10. PubMed ID: 26511357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes.
    Okada K; Hibi K; Gohbara M; Kataoka S; Takano K; Akiyama E; Matsuzawa Y; Saka K; Maejima N; Endo M; Iwahashi N; Tsukahara K; Kosuge M; Ebina T; Fitzgerald PJ; Honda Y; Umemura S; Kimura K
    Cardiovasc Diabetol; 2015 Aug; 14():111. PubMed ID: 26289581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose Variability Based on Continuous Glucose Monitoring Assessment Is Associated with Postoperative Complications after Cardiovascular Surgery.
    Sato H; Hosojima M; Ishikawa T; Aoki K; Okamoto T; Saito A; Tsuchida M
    Ann Thorac Cardiovasc Surg; 2017 Oct; 23(5):239-247. PubMed ID: 28717057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission plasma glucose levels within the normal to mildly impaired range and the outcome of patients with acute coronary syndrome.
    Buturlin K; Minha S; Rozenbaum Z; Neuman Y; Shlezinger M; Goldenberg I; Mosseri M; Pereg D
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):738-743. PubMed ID: 27037239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of intraday glucose variability on coronary artery spasm in patients with dysglycemia.
    Ito T; Ichihashi T; Fujita H; Sugiura T; Yamamoto J; Kitada S; Nakasuka K; Kawada Y; Ohte N
    Heart Vessels; 2019 Aug; 34(8):1250-1257. PubMed ID: 30712094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct impacts of sleep-disordered breathing on glycemic variability in patients with and without diabetes mellitus.
    Nakata K; Miki T; Tanno M; Ohnishi H; Yano T; Muranaka A; Sato T; Oshima H; Tatekoshi Y; Mizuno M; Abe K; Miura T
    PLoS One; 2017; 12(12):e0188689. PubMed ID: 29261679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.
    Timóteo AT; Papoila AL; Rio P; Miranda F; Ferreira ML; Ferreira RC
    Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):257-63. PubMed ID: 24687188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE-A multicenter randomized controlled trial.
    Yamamoto H; Konishi A; Shinke T; Otake H; Kuroda M; Osue T; Sawada T; Takaya T; Kawai H; Hashimoto N; Ohara T; Hirota Y; Sakaguchi K; Omori T; Ogawa W; Hirata KI
    BMC Cardiovasc Disord; 2021 Feb; 21(1):92. PubMed ID: 33588758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.